CLINICAL_TRIALS
trial_result
· 2016-11-08
Clinical Trial Update: Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia [Phase 4]
Summary
A Phase 4 safety study of the antipsychotic Sertindole for schizophrenia has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED